These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4893737)

  • 61. Combinations of 4-aminobenzoic acid competitors and dihydrofolate dehydrogenase inhibitors in the chemotherapy of malaria. A commentary.
    Laing AB
    Bull World Health Organ; 1974; 50(3-4):231-4. PubMed ID: 4613505
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Studies on the chemotherapy of malaria. II. Pyrimethamine resistance in The Gambia.
    Laing AB
    Trans R Soc Trop Med Hyg; 1970; 64(4):569-80. PubMed ID: 4922133
    [No Abstract]   [Full Text] [Related]  

  • 63. A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar.
    Dixon KE; Williams RG; Pongsupat T; Pitaktong U; Phintuyothin P
    Trans R Soc Trop Med Hyg; 1982; 76(5):664-7. PubMed ID: 6758224
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Drug resistance of Plasmodium falciparum and Plasmodium vivax strains in Cambodia (Cardamone Massif). Morphological characteristics of Plasmodium vivax].
    Lapierre J; Coquelin B; Galal AA; Dupouy-Camet J; Faurant C; Tourte-Schaefer C; Ancelle T; Heyer F
    Med Trop (Mars); 1984; 44(4):339-49. PubMed ID: 6394948
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Management of chloroquine resistant falciparum malaria.
    Blount RE
    Trans Am Clin Climatol Assoc; 1967; 78():196-204. PubMed ID: 5339079
    [No Abstract]   [Full Text] [Related]  

  • 66. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
    Kublin JG; Dzinjalamala FK; Kamwendo DD; Malkin EM; Cortese JF; Martino LM; Mukadam RA; Rogerson SJ; Lescano AG; Molyneux ME; Winstanley PA; Chimpeni P; Taylor TE; Plowe CV
    J Infect Dis; 2002 Feb; 185(3):380-8. PubMed ID: 11807721
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
    Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ
    Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sulphadoxine and pyrimethamine as treatment for acute Plasmodium falciparum malaria.
    Simpson B; Jamieson WS; Dimond AH
    Trans R Soc Trop Med Hyg; 1972; 66(2):222-4. PubMed ID: 4558823
    [No Abstract]   [Full Text] [Related]  

  • 69. [Value of the association of sulformethoxine (fanasil) and pyrimethamine in the radical treatment of malaria due to Plasmodium falciparum].
    Chum-Chantholl
    Bull Soc Pathol Exot Filiales; 1968; 61(6):858-79. PubMed ID: 4906136
    [No Abstract]   [Full Text] [Related]  

  • 70. [Chemoprophylaxis of malaria in travelers to endemic zones].
    de Górgolas Hernández-Mora M; Blanco García A; Martín Torres MP; Fernández Guerrero ML
    Rev Clin Esp; 1998 Jun; 198(6):364-8. PubMed ID: 9691743
    [No Abstract]   [Full Text] [Related]  

  • 71. A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre, Brazil.
    Kremsner PG; Zotter GM; Feldmeier H; Graninger W; Rocha RM; Wiedermann G
    J Infect Dis; 1988 Dec; 158(6):1368-71. PubMed ID: 3058821
    [No Abstract]   [Full Text] [Related]  

  • 72. Anti malarial drugs for prevention of malaria.
    Mathew JL
    Indian Pediatr; 2008 Aug; 45(8):681-3. PubMed ID: 18723912
    [No Abstract]   [Full Text] [Related]  

  • 73. Supplemental folates in the therapy of Plasmodium falciparum malaria.
    Tong MJ; Strickland GT; Votteri BA; Gunning JJ
    JAMA; 1970 Dec; 214(13):2330-3. PubMed ID: 4922770
    [No Abstract]   [Full Text] [Related]  

  • 74. Resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine combination in semi-immune children in Zaria, northern Nigeria.
    Lege-Oguntoye L; Adagu SI; Werblinska B; Ogala WN; Slotboom AB
    Trans R Soc Trop Med Hyg; 1990; 84(4):505-6. PubMed ID: 2091339
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antimalarial activity of Kelfizina-trimethoprim and Kelfizina-pyrimethamine versus chloroquine in field trials in Nigeria.
    Donno L; Sanguineti V; Ricciardi ML; Soldati M
    Am J Trop Med Hyg; 1969 Mar; 18(2):182-7. PubMed ID: 4888027
    [No Abstract]   [Full Text] [Related]  

  • 76. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Treatment of cerebral malaria with a fansidar-hydergine combination].
    Diop Mar I; Sow A
    Bull Soc Med Afr Noire Lang Fr; 1973; 18(3):357-66. PubMed ID: 4206282
    [No Abstract]   [Full Text] [Related]  

  • 78. Responsibility for failure of sulphonamides in falciparum malaria; host or parasite?
    Clyde DF
    Trans R Soc Trop Med Hyg; 1972; 66(5):806-7. PubMed ID: 4567255
    [No Abstract]   [Full Text] [Related]  

  • 79. Determination of plasma concentrations of dapsone, monoacetyl dapsone and pyrimethamine in human subjects dosed with maloprim.
    Jones CR; Ovenell SM
    J Chromatogr; 1979 Jun; 163(2):179-85. PubMed ID: 541369
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reduction of haematocrit and red-blood-cell volume in patients with polycythaemia secondary to hypoxic lung disease by dapsone and pyrimethamine.
    Pengelly CD
    Lancet; 1966 Dec; 2(7478):1381-6. PubMed ID: 4163544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.